Celano Michael 4
4 · Larimar Therapeutics, Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Celano Michael
Chief Financial Officer
Transactions
- Award
Common Stock
2025-01-22+34,185→ 178,181 total - Award
Stock Option (Right to Buy)
2025-01-22+205,111→ 205,111 totalExercise: $3.46Exp: 2035-01-22→ Common Stock (205,111 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.